The global clinical immunodiagnostics market was valued at USD 4.8 Billion in 2022 and is expected to reach USD 8.4 Billion by 2033. The immunoassay kits & reagents segment with a market share of more than 67.0% has topped the global market within the product category and is expected to grow at a CAGR of close to 5.4% over the forecast period (2023 to 2033).
Market Outlook:
Data Points | Market Insights |
---|---|
Clinical Immunodiagnostics Market Value 2022 | USD 4.8 Billion |
Market Value 2023 | USD 5.0 Billion |
Market Value 2033 | USD 8.4 Billion |
CAGR 2023 to 2033 | 5.4% |
Market Share of Top 5 Countries (2022) | 58.0% |
Clinical immunodiagnostics refers to the diagnostic tests and technologies that utilize immunodiagnostic techniques to detect and measure specific antibodies, antigens, or immune markers in patient samples. Immunodiagnostics involves the interaction between antigens and antibodies, forming an immune complex that is then detected and quantified to provide diagnostic information.
Clinical immunodiagnostics plays a crucial role in diagnosing various diseases and conditions, monitoring treatment efficacy, and assessing immune system function. These tests are commonly used in clinical laboratories, hospitals, and research institutions to identify and measure immune markers associated with infectious diseases, autoimmune disorders, allergies, cancer, and other medical conditions.
The global market for clinical immunodiagnostics was around 3.7% of the overall USD 128.2 Billion of the global in vitro diagnostics market in 2022.
The market has experienced significant growth over the years. The increasing prevalence of infectious diseases, autoimmune disorders, and cancer, coupled with advancements in immunodiagnostic technologies, has contributed to the expansion of the market.
The introduction of novel assays improved the sensitivity and specificity of tests, and the adoption of automated platforms has played a key role in the historic growth of the clinical immunodiagnostics market. The global burden of infectious diseases, chronic diseases, and conditions related to the immune system is expected to rise continuously in the coming years.
This will drive the demand for accurate and reliable diagnostic tests, including clinical immunodiagnostics. Also, the need for early disease detection, personalized medicine, and effective monitoring of treatment outcomes will fuel market growth.
Ongoing advancements in immunodiagnostic technologies, such as multiplex assays, high-sensitivity detection methods, and point-of-care testing, are expected to enhance the performance and accessibility of clinical immunodiagnostics. These technological advancements will enable rapid and accurate diagnosis, resulting in increased adoption and market growth.
Owed to the above factors, the global market is projected to grow at a CAGR of 5.4% in the forecasted period.
Clinical Immunodiagnostics are essential in personalized medicine because it helps in facilitating the diagnosis and monitoring of diseases at an individual level. As the demand for personalized treatment options continues to rise, clinical immunodiagnostics product manufacturers have an opportunity to develop innovative assays that enable targeted therapies and precision medicine.
The integration of clinical immunodiagnostics with therapeutics, particularly in oncology, presents opportunities for manufacturers. As targeted therapies become more prevalent, the demand for companion diagnostics is likely to grow. Developing tests that identify patients who will respond positively to specific treatments can enhance the effectiveness of therapies and reduce healthcare costs. Manufacturers can collaborate with pharmaceutical companies to develop companion diagnostic assays that enhance treatment selection and personalized patient care. This would present numerous opportunities for the growth of this market.
Clinical immunodiagnostics can involve high costs, including the development and production of assays, instruments, and reagents. The high costs associated with immunodiagnostic tests can limit their accessibility and affordability, particularly in resource-constrained settings or regions with limited healthcare budgets. Cost considerations can impact the demand for clinical immunodiagnostics.
Apart from this, clinical immunodiagnostics faces competition from alternative diagnostic technologies, such as molecular diagnostics, imaging techniques, and other non-immunological assays. These alternative technologies may offer advantages in terms of sensitivity, specificity, multiplexing capabilities, or cost-effectiveness in certain applications. The availability of alternative diagnostic options can limit the demand for clinical immunodiagnostics.
The USA occupies 91.1% of the North America market in 2022. Reimbursement policies play an important role in the adoption of medical technologies. In the USA, favorable reimbursement policies for clinical immunodiagnostics testing have supported market growth. Reimbursement coverage by government programs like Medicare and private insurance companies has incentivized healthcare providers to offer clinical immunodiagnostic-based diagnostics.
Germany’s expenditure in clinical immunodiagnostics in 2022 was USD 310.6 Million. Personalized medicine, which involves tailoring medical treatment to individual patients based on their genetic profile, is gaining prominence in this region. Germany, known for its strong healthcare and research infrastructure, is actively participating in personalized medicine initiatives. Clinical immunodiagnostics being essential in identifying specific biomarkers for personalized medicine drives the demand for various kits and reagents in the country.
In 2022, China held a significant share of the East Asia market and is expected to grow at a CAGR of close to 6.4% over the forecast period. Chinese clinical immunodiagnostics manufacturers are increasingly collaborating with international companies, leveraging expertise, technologies, and market access. These collaborations help in technology transfer, product development, and expanding the market reach of clinical immunodiagnostics in China. Also, partnerships with healthcare providers and research institutions contribute to the growth of the clinical immunodiagnostics market in China.
By product, immunoassay kits & reagents held 67.8% market share in the world in 2022 and are expected to expand rapidly with a CAGR of 5.4% from 2023 to 2033. Immunoassay kits and reagents have a broad range of applications in clinical immunodiagnostics, covering various disease areas, including infectious diseases, autoimmune disorders, oncology, cardiovascular diseases, and endocrinology. Their versatility and adaptability to different analytes make them essential tools for diagnosing and monitoring a diverse set of medical conditions.
The market value of serum sample type was USD 1.7 Billion, representing a sizable 35.4% market share in 2022. Serum samples are readily available and routinely used in clinical practice. Healthcare facilities and laboratories can easily collect serum samples from patients for diagnostic testing, making them a convenient and accessible source of biomaterial for immunodiagnostics.
By application, infectious disease accounted for a prominent share of the global market, with a revenue share of 20.7% in 2022. Infectious diseases are widespread and continue to pose a significant global health burden. The high prevalence of infectious diseases, such as influenza, HIV/AIDS, hepatitis, tuberculosis, and various respiratory infections, drives the demand for diagnostic tests based on immunodiagnostics.
With a 26.1% value share in 2022 and a strong CAGR of 6.4% over the projected period, the hospital has a sizable position in this market. Hospitals cater to a large number of patients with diverse medical conditions. As a result, they have a substantial demand for diagnostic testing, including clinical immunodiagnostics. Hospitals frequently utilize immunodiagnostic tests to aid in the diagnosis and inspection of various diseases.
Collaborations with medical professionals, academic institutions, and IT companies can promote creativity and speed up clinical immunodiagnostics. Also, collaboration in research, development, and commercialization can result in new applications and a larger market. The market for clinical immunodiagnostics is dominated by multiple sizable businesses. The important advances of the major companies in this market are illustrated by the following examples:
Similarly, recent developments related to the companies, manufacturing the clinical immunodiagnostics products have been tracked by the team at Future Market Insights, which are available in the full report.
Report Attributes | Details |
---|---|
Forecast Period | 2023 to 2033 |
Historical Data Available for | 2017 to 2022 |
Market Analysis | USD Million for Value, Units for Volume |
Key Regions Covered | North America; Latin America; Europe; East Asia; South Asia; Oceania; Middle East and Africa (MEA) |
Key Countries Covered | USA, Canada, Brazil, Mexico, Argentina, United Kingdom, Germany, Italy, France, Spain, BENELUX, Russia, China, Japan, South Korea, India, Indonesia, Thailand, Malaysia, Australia, New Zealand, GCC Countries, Türkiye, South Africa and Northern Africa |
Key Market Segments Covered | Product, Sample Type, Application, End User, and Region |
Key Companies Profiled | Surmodics, Inc.; MESO SCALE DIAGNOSTICS, LLC.; Abbott; Siemens Healthineers; PerkinElmer Inc.; Becton, Dickinson and Company; Thermo Fisher Scientific Inc.; Zoetis Inc.; Promega Corporation; F. Hoffmann-La Roche; BIOMÉRIEUX SA; Elabscience Biotechnology Inc.; Innovative Research, Inc.; QIAGEN N.V.; Merck KGaA; Bio-Rad Laboratories, Inc.; Creative Diagnostics; Cell Signaling Technology (CST); NEW HORIZONS DIAGNOSTIC CORPORATION; DiaSorin S.p.A.; H.U. Group Holdings Inc; IDEXX Laboratories Inc.; Randox Laboratories Ltd.; Biopanda Reagents Ltd.; Shenzhen Bioeasy Biotechnology Co., Ltd.; Quidel Corporation; Advnt Biotechnologies.; RESPONSE BIOMEDICAL.; Danaher Corporation |
Report Coverage | Market Forecast, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, Strategic Growth Initiatives |
Pricing | Available upon Request |
Table 01: Global Market Value (US$ Million) Analysis and Forecast 2017 to 2033, by Product
Table 02: Global Market Volume (Units) Analysis and Forecast 2017 to 2033, by Product
Table 03: Global Market Value (US$ Million) Analysis and Forecast 2017 to 2033, by Sample Type
Table 04: Global Market Value (US$ Million) Analysis and Forecast 2017 to 2033, by Application
Table 05: Global Market Value (US$ Million) Analysis and Forecast 2017 to 2033, by End User
Table 06: Global Market Value (US$ Million) Analysis and Forecast 2017 to 2033, by Region
Table 07: North America Market Value (US$ Million) Analysis 2017 to 2022 and Forecast 2023 to 2033, by Country
Table 08: North America Market Value (US$ Million) Analysis and Forecast 2017 to 2033, by Product
Table 09: North America Market Volume (Units) Analysis and Forecast 2017 to 2033, by Product
Table 10: North America Market Value (US$ Million) Analysis and Forecast 2017 to 2033, by Sample Type
Table 11: North America Market Value (US$ Million) Analysis and Forecast 2017 to 2033, by Application
Table 12: North America Market Value (US$ Million) Analysis and Forecast 2017 to 2033, by End User
Table 13: Latin America Market Value (US$ Million) Analysis 2017 to 2022 and Forecast 2023 to 2033, by Country
Table 14: Latin America Market Value (US$ Million) Analysis and Forecast 2017 to 2033, by Product
Table 15: Latin America Market Volume (Units) Analysis and Forecast 2017 to 2033, by Product
Table 16: Latin America Market Value (US$ Million) Analysis and Forecast 2017 to 2033, by Sample Type
Table 17: Latin America Market Value (US$ Million) Analysis and Forecast 2017 to 2033, by Application
Table 18: Latin America Market Value (US$ Million) Analysis and Forecast 2017 to 2033, by End User
Table 19: Europe Market Value (US$ Million) Analysis 2017 to 2022 and Forecast 2023 to 2033, by Country
Table 20: Europe Market Value (US$ Million) Analysis and Forecast 2017 to 2033, by Product
Table 21: Europe Market Volume (Units) Analysis and Forecast 2017 to 2033, by Product
Table 22: Europe Market Value (US$ Million) Analysis and Forecast 2017 to 2033, by Sample Type
Table 23: Europe Market Value (US$ Million) Analysis and Forecast 2017 to 2033, by Application
Table 24: Europe Market Value (US$ Million) Analysis and Forecast 2017 to 2033, by End User
Table 25: East Asia Market Value (US$ Million) Analysis 2017 to 2022 and Forecast 2023 to 2033, by Country
Table 26: East Asia Market Value (US$ Million) Analysis and Forecast 2017 to 2033, by Product
Table 27: East Asia Market Volume (Units) Analysis and Forecast 2017 to 2033, by Product
Table 28: East Asia Market Value (US$ Million) Analysis and Forecast 2017 to 2033, by Sample Type
Table 29: East Asia Market Value (US$ Million) Analysis and Forecast 2017 to 2033, by Application
Table 30: East Asia Market Value (US$ Million) Analysis and Forecast 2017 to 2033, by End User
Table 31: South Asia Market Value (US$ Million) Analysis 2017 to 2022 and Forecast 2023 to 2033, by Country
Table 32: South Asia Market Value (US$ Million) Analysis and Forecast 2017 to 2033, by Product
Table 33: South Asia Market Volume (Units) Analysis and Forecast 2017 to 2033, by Product
Table 34: South Asia Market Value (US$ Million) Analysis and Forecast 2017 to 2033, by Sample Type
Table 35: South Asia Market Value (US$ Million) Analysis and Forecast 2017 to 2033, by Application
Table 36: South Asia Market Value (US$ Million) Analysis and Forecast 2017 to 2033, by End User
Table 37: Oceania Market Value (US$ Million) Analysis 2017 to 2022 and Forecast 2023 to 2033, by Country
Table 38: Oceania Market Value (US$ Million) Analysis and Forecast 2017 to 2033, by Product
Table 39: Oceania Market Volume (Units) Analysis and Forecast 2017 to 2033, by Product
Table 40: Oceania Market Value (US$ Million) Analysis and Forecast 2017 to 2033, by Sample Type
Table 41: Oceania Market Value (US$ Million) Analysis and Forecast 2017 to 2033, by Application
Table 42: Oceania Market Value (US$ Million) Analysis and Forecast 2017 to 2033, by End User
Table 43: Middle East & Africa Market Value (US$ Million) Analysis 2017 to 2022 and Forecast 2023 to 2033, by Country
Table 44: Middle East & Africa Market Value (US$ Million) Analysis and Forecast 2017 to 2033, by Product
Table 45: Middle East & Africa Market Volume (Units) Analysis and Forecast 2017 to 2033, by Product
Table 46: Middle East & Africa Market Value (US$ Million) Analysis and Forecast 2017 to 2033, by Sample Type
Table 47: Middle East & Africa Market Value (US$ Million) Analysis and Forecast 2017 to 2033, by Application
Table 48: Middle East & Africa Market Value (US$ Million) Analysis and Forecast 2017 to 2033, by End User
Figure 01: Global Market Volume (Units), 2017 to 2022
Figure 02: Global Market Volume (Units) & Y-o-Y Growth (%) Analysis, 2023 to 2033
Figure 03: Clinical Immunodiagnostic Product, Pricing Analysis per unit (US$), in 2022
Figure 04: Clinical Immunodiagnostic Product, Pricing Forecast per unit (US$), in 2033
Figure 05: Global Market Value (US$ Million) Analysis, 2017 to 2022
Figure 06: Global Market Forecast & Y-o-Y Growth, 2023 to 2033
Figure 07: Global Market Absolute $ Opportunity (US$ Million) Analysis, 2022 to 2033
Figure 08: Global Market Value Share (%) Analysis 2023 and 2033, by Product
Figure 09: Global Market Y-o-Y Growth (%) Analysis 2022-2033, by Product
Figure 10: Global Market Attractiveness Analysis 2023 to 2033, by Product
Figure 11: Global Market Value Share (%) Analysis 2023 and 2033, by Sample Type
Figure 12: Global Market Y-o-Y Growth (%) Analysis 2022-2033, by Sample Type
Figure 13: Global Market Attractiveness Analysis 2023 to 2033, by Sample Type
Figure 14: Global Market Value Share (%) Analysis 2023 and 2033, by Application
Figure 15: Global Market Y-o-Y Growth (%) Analysis 2022-2033, by Application
Figure 16: Global Market Attractiveness Analysis 2023 to 2033, by Application
Figure 17: Global Market Value Share (%) Analysis 2023 and 2033, by End User
Figure 18: Global Market Y-o-Y Growth (%) Analysis 2022-2033, by End User
Figure 19: Global Market Attractiveness Analysis 2023 to 2033, by End User
Figure 20: Global Market Value Share (%) Analysis 2023 and 2033, by Region
Figure 21: Global Market Y-o-Y Growth (%) Analysis 2022-2033, by Region
Figure 22: Global Market Attractiveness Analysis 2023 to 2033, by Region
Figure 23: North America Market Value (US$ Million) Analysis, 2017 to 2022
Figure 24: North America Market Value (US$ Million) Forecast, 2023 to 2033
Figure 25: North America Market Value Share, by Product (2023 E)
Figure 26: North America Market Value Share, by Sample Type (2023 E)
Figure 27: North America Market Value Share, by Application (2023 E)
Figure 28: North America Market Value Share, by End User (2023 E)
Figure 29: North America Market Value Share, by Country (2023 E)
Figure 30: North America Market Attractiveness Analysis by Product, 2023 to 2033
Figure 31: North America Market Attractiveness Analysis by Sample Type, 2023 to 2033
Figure 32: North America Market Attractiveness Analysis by Application, 2023 to 2033
Figure 33: North America Market Attractiveness Analysis by End User, 2023 to 2033
Figure 34: North America Market Attractiveness Analysis by Country, 2023 to 2033
Figure 35: USA. Market Value Proportion Analysis, 2022
Figure 36: Global Vs. USA. Growth Comparison
Figure 37: USA. Market Share Analysis (%) by Product, 2022 & 2033
Figure 38: USA. Market Share Analysis (%) by Sample Type, 2022 & 2033
Figure 39: USA. Market Share Analysis (%) by Application, 2022 & 2033
Figure 40: USA. Market Share Analysis (%) by End User, 2022 & 2033
Figure 41: Canada Market Value Proportion Analysis, 2022
Figure 42: Global Vs. Canada. Growth Comparison
Figure 43: Canada Market Share Analysis (%) by Product, 2022 & 2033
Figure 44: Canada Market Share Analysis (%) by Sample Type, 2022 & 2033
Figure 45: Canada Market Share Analysis (%) by Application, 2022 & 2033
Figure 46: Canada Market Share Analysis (%) by End User, 2022 & 2033
Figure 47: Latin America Market Value (US$ Million) Analysis, 2017 to 2022
Figure 48: Latin America Market Value (US$ Million) Forecast, 2023 to 2033
Figure 49: Latin America Market Value Share, by Product (2023 E)
Figure 50: Latin America Market Value Share, by Sample Type (2023 E)
Figure 51: Latin America Market Value Share, by Application (2023 E)
Figure 52: Latin America Market Value Share, by End User (2023 E)
Figure 53: Latin America Market Value Share, by Country (2023 E)
Figure 54: Latin America Market Attractiveness Analysis by Product, 2023 to 2033
Figure 55: Latin America Market Attractiveness Analysis by Sample Type, 2023 to 2033
Figure 56: Latin America Market Attractiveness Analysis by Application, 2023 to 2033
Figure 57: Latin America Market Attractiveness Analysis by End User, 2023 to 2033
Figure 58: Latin America Market Attractiveness Analysis by Country, 2023 to 2033
Figure 59: Mexico Market Value Proportion Analysis, 2022
Figure 60: Global Vs Mexico Growth Comparison
Figure 61: Mexico Market Share Analysis (%) by Product, 2022 & 2033
Figure 62: Mexico Market Share Analysis (%) by Sample Type, 2022 & 2033
Figure 63: Mexico Market Share Analysis (%) by Application, 2022 & 2033
Figure 64: Mexico Market Share Analysis (%) by End User, 2022 & 2033
Figure 65: Brazil Market Value Proportion Analysis, 2022
Figure 66: Global Vs. Brazil. Growth Comparison
Figure 67: Brazil Market Share Analysis (%) by Product, 2022 & 2033
Figure 68: Brazil Market Share Analysis (%) by Sample Type, 2022 & 2033
Figure 69: Brazil Market Share Analysis (%) by Application, 2022 & 2033
Figure 70: Brazil Market Share Analysis (%) by End User, 2022 & 2033
Figure 71: Argentina Market Value Proportion Analysis, 2022
Figure 72: Global Vs Argentina Growth Comparison
Figure 73: Argentina Market Share Analysis (%) by Product, 2022 & 2033
Figure 74: Argentina Market Share Analysis (%) by Sample Type, 2022 & 2033
Figure 75: Argentina Market Share Analysis (%) by Application, 2022 & 2033
Figure 76: Argentina Market Share Analysis (%) by End User, 2022 & 2033
Figure 77: Europe Market Value (US$ Million) Analysis, 2017 to 2022
Figure 78: Europe Market Value (US$ Million) Forecast, 2023 to 2033
Figure 79: Europe Market Value Share, by Product (2023 E)
Figure 80: Europe Market Value Share, by Sample Type (2023 E)
Figure 81: Europe Market Value Share, by Application (2023 E)
Figure 82: Europe Market Value Share, by End User (2023 E)
Figure 83: Europe Market Value Share, by Country (2023 E)
Figure 84: Europe Market Attractiveness Analysis by Product, 2023 to 2033
Figure 85: Europe Market Attractiveness Analysis by Sample Type, 2023 to 2033
Figure 86: Europe Market Attractiveness Analysis by Application, 2023 to 2033
Figure 87: Europe Market Attractiveness Analysis by End User, 2023 to 2033
Figure 88: Europe Market Attractiveness Analysis by Country, 2023 to 2033
Figure 89: United Kingdom. Market Value Proportion Analysis, 2022
Figure 90: Global Vs. United Kingdom. Growth Comparison
Figure 91: United Kingdom. Market Share Analysis (%) by Product, 2022 & 2033
Figure 92: United Kingdom. Market Share Analysis (%) by Sample Type, 2022 & 2033
Figure 93: United Kingdom. Market Share Analysis (%) by Application, 2022 & 2033
Figure 94: United Kingdom. Market Share Analysis (%) by End User, 2022 & 2033
Figure 95: Germany Market Value Proportion Analysis, 2022
Figure 96: Global Vs. Germany Growth Comparison
Figure 97: Germany Market Share Analysis (%) by Product, 2022 & 2033
Figure 98: Germany Market Share Analysis (%) by Sample Type, 2022 & 2033
Figure 99: Germany Market Share Analysis (%) by Application, 2022 & 2033
Figure 100: Germany Market Share Analysis (%) by End User, 2022 & 2033
Figure 101: Italy Market Value Proportion Analysis, 2022
Figure 102: Global Vs. Italy Growth Comparison
Figure 103: Italy Market Share Analysis (%) by Product, 2022 & 2033
Figure 104: Italy Market Share Analysis (%) by Sample Type, 2022 & 2033
Figure 105: Italy Market Share Analysis (%) by Application, 2022 & 2033
Figure 106: Italy Market Share Analysis (%) by End User, 2022 & 2033
Figure 107: France Market Value Proportion Analysis, 2022
Figure 108: Global Vs France Growth Comparison
Figure 109: France Market Share Analysis (%) by Product, 2022 & 2033
Figure 110: France Market Share Analysis (%) by Sample Type, 2022 & 2033
Figure 111: France Market Share Analysis (%) by Application, 2022 & 2033
Figure 112: France Market Share Analysis (%) by End User, 2022 & 2033
Figure 113: Spain Market Value Proportion Analysis, 2022
Figure 114: Global Vs Spain Growth Comparison
Figure 115: Spain Market Share Analysis (%) by Product, 2022 & 2033
Figure 116: Spain Market Share Analysis (%) by Sample Type, 2022 & 2033
Figure 117: Spain Market Share Analysis (%) by Application, 2022 & 2033
Figure 118: Spain Market Share Analysis (%) by End User, 2022 & 2033
Figure 119: Russia Market Value Proportion Analysis, 2022
Figure 120: Global Vs Russia Growth Comparison
Figure 121: Russia Market Share Analysis (%) by Product, 2022 & 2033
Figure 122: Russia Market Share Analysis (%) by Sample Type, 2022 & 2033
Figure 123: Russia Market Share Analysis (%) by Application, 2022 & 2033
Figure 124: Russia Market Share Analysis (%) by End User, 2022 & 2033
Figure 125: BENELUX Market Value Proportion Analysis, 2022
Figure 126: Global Vs BENELUX Growth Comparison
Figure 127: BENELUX Market Share Analysis (%) by Product, 2022 & 2033
Figure 128: BENELUX Market Share Analysis (%) by Sample Type, 2022 & 2033
Figure 129: BENELUX Market Share Analysis (%) by Application, 2022 & 2033
Figure 130: BENELUX Market Share Analysis (%) by End User, 2022 & 2033
Figure 131: East Asia Market Value (US$ Million) Analysis, 2017 to 2022
Figure 132: East Asia Market Value (US$ Million) Forecast, 2023 to 2033
Figure 133: East Asia Market Value Share, by Product (2023 E)
Figure 134: East Asia Market Value Share, by Sample Type (2023 E)
Figure 135: East Asia Market Value Share, by Application (2023 E)
Figure 136: East Asia Market Value Share, by End User (2023 E)
Figure 137: East Asia Market Value Share, by Country (2023 E)
Figure 138: East Asia Market Attractiveness Analysis by Product, 2023 to 2033
Figure 139: East Asia Market Attractiveness Analysis by Sample Type, 2023 to 2033
Figure 140: East Asia Market Attractiveness Analysis by Application, 2023 to 2033
Figure 141: East Asia Market Attractiveness Analysis by End User, 2023 to 2033
Figure 142: East Asia Market Attractiveness Analysis by Country, 2023 to 2033
Figure 143: China Market Value Proportion Analysis, 2022
Figure 144: Global Vs. China Growth Comparison
Figure 145: China Market Share Analysis (%) by Product, 2022 & 2033
Figure 146: China Market Share Analysis (%) by Sample Type, 2022 & 2033
Figure 147: China Market Share Analysis (%) by Application, 2022 & 2033
Figure 148: China Market Share Analysis (%) by End User, 2022 & 2033
Figure 149: Japan Market Value Proportion Analysis, 2022
Figure 150: Global Vs. Japan Growth Comparison
Figure 151: Japan Market Share Analysis (%) by Product, 2022 & 2033
Figure 152: Japan Market Share Analysis (%) by Sample Type, 2022 & 2033
Figure 153: Japan Market Share Analysis (%) by Application, 2022 & 2033
Figure 154: Japan Market Share Analysis (%) by End User, 2022 & 2033
Figure 155: South Korea Market Value Proportion Analysis, 2022
Figure 156: Global Vs South Korea Growth Comparison
Figure 157: South Korea Market Share Analysis (%) by Product, 2022 & 2033
Figure 158: South Korea Market Share Analysis (%) by Sample Type, 2022 & 2033
Figure 159: South Korea Market Share Analysis (%) by Application, 2022 & 2033
Figure 160: South Korea Market Share Analysis (%) by End User, 2022 & 2033
Figure 161: South Asia Market Value (US$ Million) Analysis, 2017 to 2022
Figure 162: South Asia Market Value (US$ Million) Forecast, 2023 to 2033
Figure 163: South Asia Market Value Share, by Product (2023 E)
Figure 164: South Asia Market Value Share, by Sample Type (2023 E)
Figure 165: South Asia Market Value Share, by Application (2023 E)
Figure 166: South Asia Market Value Share, by End User (2023 E)
Figure 167: South Asia Market Value Share, by Country (2023 E)
Figure 168: South Asia Market Attractiveness Analysis by Product, 2023 to 2033
Figure 169: South Asia Market Attractiveness Analysis by Sample Type, 2023 to 2033
Figure 170: South Asia Market Attractiveness Analysis by Application, 2023 to 2033
Figure 171: South Asia Market Attractiveness Analysis by End User, 2023 to 2033
Figure 172: South Asia Market Attractiveness Analysis by Country, 2023 to 2033
Figure 173: India Market Value Proportion Analysis, 2022
Figure 174: Global Vs. India Growth Comparison
Figure 175: India Market Share Analysis (%) by Product, 2022 & 2033
Figure 176: India Market Share Analysis (%) by Sample Type, 2022 & 2033
Figure 177: India Market Share Analysis (%) by Application, 2022 & 2033
Figure 178: India Market Share Analysis (%) by End User, 2022 & 2033
Figure 179: Indonesia Market Value Proportion Analysis, 2022
Figure 180: Global Vs. Indonesia Growth Comparison
Figure 181: Indonesia Market Share Analysis (%) by Product, 2022 & 2033
Figure 182: Indonesia Market Share Analysis (%) by Sample Type, 2022 & 2033
Figure 183: Indonesia Market Share Analysis (%) by Application, 2022 & 2033
Figure 184: Indonesia Market Share Analysis (%) by End User, 2022 & 2033
Figure 185: Malaysia Market Value Proportion Analysis, 2022
Figure 186: Global Vs. Malaysia Growth Comparison
Figure 187: Malaysia Market Share Analysis (%) by Product, 2022 & 2033
Figure 188: Malaysia Market Share Analysis (%) by Sample Type, 2022 & 2033
Figure 189: Malaysia Market Share Analysis (%) by Application, 2022 & 2033
Figure 190: Malaysia Market Share Analysis (%) by End User, 2022 & 2033
Figure 191: Thailand Market Value Proportion Analysis, 2022
Figure 192: Global Vs. Thailand Growth Comparison
Figure 193: Thailand Market Share Analysis (%) by Product, 2022 & 2033
Figure 194: Thailand Market Share Analysis (%) by Sample Type, 2022 & 2033
Figure 195: Thailand Market Share Analysis (%) by Application, 2022 & 2033
Figure 196: Thailand Market Share Analysis (%) by End User, 2022 & 2033
Figure 197: Oceania Market Value (US$ Million) Analysis, 2017 to 2022
Figure 198: Oceania Market Value (US$ Million) Forecast, 2023 to 2033
Figure 199: Oceania Market Value Share, by Product (2023 E)
Figure 200: Oceania Market Value Share, by Sample Type (2023 E)
Figure 201: Oceania Market Value Share, by Application (2023 E)
Figure 202: Oceania Market Value Share, by End User (2023 E)
Figure 203: Oceania Market Value Share, by Country (2023 E)
Figure 204: Oceania Market Attractiveness Analysis by Product, 2023 to 2033
Figure 205: Oceania Market Attractiveness Analysis by Sample Type, 2023 to 2033
Figure 206: Oceania Market Attractiveness Analysis by Application, 2023 to 2033
Figure 207: Oceania Market Attractiveness Analysis by End User, 2023 to 2033
Figure 208: Oceania Market Attractiveness Analysis by Country, 2023 to 2033
Figure 209: Australia Market Value Proportion Analysis, 2022
Figure 210: Global Vs. Australia Growth Comparison
Figure 211: Australia Market Share Analysis (%) by Product, 2022 & 2033
Figure 212: Australia Market Share Analysis (%) by Sample Type, 2022 & 2033
Figure 213: Australia Market Share Analysis (%) by Application, 2022 & 2033
Figure 214: Australia Market Share Analysis (%) by End User, 2022 & 2033
Figure 215: New Zealand Market Value Proportion Analysis, 2022
Figure 216: Global Vs New Zealand Growth Comparison
Figure 217: New Zealand Market Share Analysis (%) by Product, 2022 & 2033
Figure 218: New Zealand Market Share Analysis (%) by Sample Type, 2022 & 2033
Figure 219: New Zealand Market Share Analysis (%) by Application, 2022 & 2033
Figure 220: New Zealand Market Share Analysis (%) by End User, 2022 & 2033
Figure 221: Middle East & Africa Market Value (US$ Million) Analysis, 2017 to 2022
Figure 222: Middle East & Africa Market Value (US$ Million) Forecast, 2023 to 2033
Figure 223: Middle East & Africa Market Value Share, by Product (2023 E)
Figure 224: Middle East & Africa Market Value Share, by Sample Type (2023 E)
Figure 225: Middle East & Africa Market Value Share, by Application (2023 E)
Figure 226: Middle East & Africa Market Value Share, by End User (2023 E)
Figure 227: Middle East & Africa Market Value Share, by Country (2023 E)
Figure 228: Middle East & Africa Market Attractiveness Analysis by Product, 2023 to 2033
Figure 229: Middle East & Africa Market Attractiveness Analysis by Sample Type, 2023 to 2033
Figure 230: Middle East & Africa Market Attractiveness Analysis by Application, 2023 to 2033
Figure 231: Middle East & Africa Market Attractiveness Analysis by End User, 2023 to 2033
Figure 232: Middle East & Africa Market Attractiveness Analysis by Country, 2023 to 2033
Figure 233: GCC Countries Market Value Proportion Analysis, 2022
Figure 234: Global Vs GCC Countries Growth Comparison
Figure 235: GCC Countries Market Share Analysis (%) by Product, 2022 & 2033
Figure 236: GCC Countries Market Share Analysis (%) by Sample Type, 2022 & 2033
Figure 237: GCC Countries Market Share Analysis (%) by Application, 2022 & 2033
Figure 238: GCC Countries Market Share Analysis (%) by End User, 2022 & 2033
Figure 239: Türkiye Market Value Proportion Analysis, 2022
Figure 240: Global Vs. Türkiye Growth Comparison
Figure 241: Türkiye Market Share Analysis (%) by Product, 2022 & 2033
Figure 242: Türkiye Market Share Analysis (%) by Sample Type, 2022 & 2033
Figure 243: Türkiye Market Share Analysis (%) by Application, 2022 & 2033
Figure 244: Türkiye Market Share Analysis (%) by End User, 2022 & 2033
Figure 245: South Africa Market Value Proportion Analysis, 2022
Figure 246: Global Vs. South Africa Growth Comparison
Figure 247: South Africa Market Share Analysis (%) by Product, 2022 & 2033
Figure 248: South Africa Market Share Analysis (%) by Sample Type, 2022 & 2033
Figure 249: South Africa Market Share Analysis (%) by Application, 2022 & 2033
Figure 250: South Africa Market Share Analysis (%) by End User, 2022 & 2033
Figure 251: Northern Africa Market Value Proportion Analysis, 2022
Figure 252: Global Vs Northern Africa Growth Comparison
Figure 253: Northern Africa Market Share Analysis (%) by Product, 2022 & 2033
Figure 254: Northern Africa Market Share Analysis (%) by Sample Type, 2022 & 2033
Figure 255: Northern Africa Market Share Analysis (%) by Application, 2022 & 2033
Figure 256: Northern Africa Market Share Analysis (%) by End User, 2022 & 2033
The clinical immunodiagnostics market size is valued at USD 5.0 billion in 2023.
The United States occupied 91.1% of the North American clinical immunodiagnostics market share in 2022.
China’s clinical immunodiagnostics market in East Asia rose at a 6.4% CAGR in 2022.
The immunoassay kits & reagents segment will thrive at a 5.4% CAGR from 2023 to 2033.
The infectious disease segment garnered 20.7% of the clinical immunodiagnostics market’s revenue share in 2022.
Explore Similar Insights
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.